⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 25, 2024Journal of Managed Care & Specialty Pharmacy

A real-world study of persistence and adherence to prescription medications in patients with chronic idiopathic constipation in the United States

Brooks D. Cash Mei Lü Anthony Lembo Paul Feuerstadt Linda Anh B. Nguyen Emi Terasawa Rajeev Ayyagari Shawn Du Selina Pi Ben Westermeyer Brian Terreri Mena Boules Baharak Moshiree

View Full Paper

Ask AI

Bookmark

Share

Abstract

At present, 4 prescription therapies have been approved by the US Food and Drug Administration for the treatment of chronic idiopathic constipation (CIC) in adults.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cash et al. (2024) studied this question.

synapsesocial.com/papers/68e5765bb6db643587516251 https://doi.org/10.18553/jmcp.2024.30.10.1136

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Treatment for chronic idiopathic constipation: Use and satisfaction from a nationwide survey of <scp>US</scp> participants2024 · 8 citations
2Laxative logic: when lifestyle is not enough.2025 · 1 citations
3Chronic constipation: current options of pathogenetic therapy2024 · 1 citations
4Step on the accelerator: modern treatment of constipationReview · 2023 · 2 citations
5Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo‐controlled trials in adults with severe constipationRCT · 2023 · 9 citations